"Predictive Biomarkers in SLE: A Journey to Personalized Healthcare"
A symposium held for the first time in Washington, DC on November 14, 2012 featured experts- from renowned institutions such as Hospital for Special Surgery, Mayo Clinic, University of California, San Diego, Johns Hopkins, and others, as well as industry leader, Genentech, Inc.- and summarized cutting-edge biomarkers research in lupus and obstacles preventing their use as predictive markers. The interdisciplinary symposium, led by Wael Jarjour, MD, FACP, brought together biomarker experts from hematology, cardiology, nephrology and rheumatology to delineate more effective strategies for the next phase in the discovery and validation of biomarkers in SLE.
2012 American College of Rheumatology Annual National Meeting in Washington, DC
Stacy Ardoin, MD presented an abstract at the 2012 ACR Meeting in Washington, DC entitled "Do Serum Hepcidin 25 Levels Predict SLE Renal or Non-Renal Flares?"
Nicholas Young, PhD presented abstracts entitled "Myosin Skews Effector Immune Cells of Scurfy Mice to Target Muscles in an Adoptive Transfer Model of Myositis" and "Estrogen Modulation of ZAS3 is Mediated Through Estrogen Receptor alpha; An Underlying Mechanism of Gender-Bias in SLE"